Zenith Drugs Limited Financial Ratios
ZENITHDRUG · Healthcare · Current price ₹41.4
P/E ratio
18.0x
P/B ratio
1.1x
ROE
5.4%
ROCE
8.6%
Debt / Equity
0.75
Dividend yield
1.1%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 18.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.1x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 5.4% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 8.6% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.75 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Zenith Drugs Limited's latest numbers.
Zenith Drugs Limited profitability
Zenith Drugs Limited generates a return on equity of 5.4% and a return on capital employed of 8.6%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.75 and a P/E of 18.0x, Zenith Drugs Limited is moderately leveraged. Our overall business-quality score for the company is 3.4 / 10.
Understand the ratios
More on Zenith Drugs Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.